FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer
Kaplan–Meier estimates of general survival (A) and progression-free survival (B) NALIRIFOX=liposomal irinotecan together with fluorouracil, leucovorin, and oxaliplatin. Credit score: ...